OncoCyte Corp.
(NYSE Amex Equities : OCX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
-0.07%74.950.8%$459.66m
MDTMedtronic PLC
0.20%92.510.6%$455.53m
ISRGIntuitive Surgical, Inc.
-0.07%547.802.4%$424.45m
TMOThermo Fisher Scientific Inc.
0.18%251.281.0%$388.53m
ALGNAlign Technology, Inc.
-0.44%254.116.3%$368.78m
SYKStryker Corporation
0.49%187.031.3%$325.63m
BSXBoston Scientific Corporation
0.04%39.881.1%$285.97m
BDXBecton, Dickinson and Company
-0.02%248.001.1%$254.58m
BAXBaxter International Inc.
0.33%73.711.7%$213.19m
EWEdwards Lifesciences Corporation
0.53%177.971.2%$211.20m
ABMDABIOMED, Inc.
-0.49%357.603.3%$200.82m
WATWaters Corporation
-0.54%233.183.5%$181.16m
ZBHZimmer Biomet Holdings, Inc.
0.27%123.891.7%$176.82m
DXCMDexCom, Inc.
-0.71%146.868.5%$155.55m
IDXXIDEXX Laboratories, Inc.
0.49%212.363.7%$110.22m

Company Profile

OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA.